Global high consequence infectious disease events: summary October 2023
Updated 3 April 2025
Interpreting this report
The report provides updates on known, high-consequence infectious disease (HCID) events around the world as monitored byÌýthe UK Health Security Agency’s (UKHSA) epidemic intelligence activities.
The report is divided into 2 sections covering all the definedÌýHCIDÌýpathogens. The first section contains contact and airborneÌýHCIDsÌýthat have been specified for theÌýHCIDÌýprogramme by NHS England. The second section contains additionalÌýHCIDsÌýthat are important for situational awareness.
Each section contains information on known pathogens and includes descriptions of recent events. If an undiagnosed disease event occurs that could be interpreted as a potentialÌýHCID, a third section will be added to the report.
Events found during routine scanning activities that occur in endemic areas will briefly be noted in the report. Active surveillance, other than daily epidemic intelligence activities, of events in endemic areas will not be conducted (for example, actively searching government websites or other sources for data on case numbers).
The target audience for this report is any healthcare professional who may be involved inÌýHCIDÌýidentification, treatment and management.
Risk rating
Included for each disease is a current risk rating based on the probability of introduction to the UK and potential impact.ÌýPast UK experience and the global occurrence of travel-associated cases are also considered. Currently, all diseases are classified into one of 3 categories: Low, Very low and Exceptionally low/negligible.
Incidents of significance of primaryÌýHCIDs
°ä´Ç²Ô³Ù²¹³¦³ÙÌýHCIDs
Crimean-Congo haemorrhagic fever (CCHF)
Geographical risk areas | Endemic in Africa, the Balkans, the Middle East and western and south-central Asia. Cases have also been reported in Russia and Georgia. Spain has previously reported locally acquired cases (, with the latest case reported in 2022). |
---|---|
Sources and routes of infection | • bite from, or crushing of, an infected tickÌý • contact with the blood, tissues or body fluids of infected humans or animals |
UKÌýexperience to dateÌýÌý | Two cases have been reported in individuals who have travelled to the UK from and |
Risk ratingÌý | Low – rarely reported in travellers. |
Recent cases or outbreaksÌý | Between 1 January and 28 October 2023, the WHO reported (case fatality rate (CFR) of 9.2%) from Afghanistan. CCHF was confirmed in 370 out of 1,052 suspected cases tested. In 2022, . On 9 October 2023, media reported that (CFR of 12.8%) had been reported in Iraq, since 1 January 2023. The highest number of confirmed cases have been reported from Dhi Qar Province (132 cases, including 13 deaths). During 2023, have been reported in Balochistan, Pakistan, as reported by media on 14 October. On 4 October 2023, media stated that in Russia’s Rostov Region in 2023. The region reported 24 confirmed cases of CCHF in 2022. |
Ebola virus disease (EVD)
Geographical risk areasÌý | Map of countries which have reported EVD cases up to January 2023. |
---|---|
Sources and routes of infectionÌýÌý | • contact with blood, tissues or body fluids of infected animals, or consumption of raw or undercooked infected animal tissue • contact with infected human blood or body fluidsÌý |
UKÌýexperience to dateÌý | Four confirmed cases (one lab-acquired in the UK in 1976, 3 healthcare workers associated with West African epidemic 2014 to 2015).Ìý |
Risk ratingÌýÌý | Very low – other than during the West Africa outbreak, exported cases are extremely rare.Ìý |
Recent cases or outbreaksÌý | No confirmed or suspected human cases were reported in October 2023. |
Lassa fever
Geographical risk areasÌý | Endemic in sub-Saharan West Africa. |
---|---|
Sources and routes of infectionÌý | • contact with excreta, or materials contaminated with excreta from an infected rodentÌý • inhalation of aerosols of excreta from an infected rodentÌý • contact with infected human blood or body fluids |
UKÌýexperience to dateÌý | . Prior to this, had been reported since 1971, all in travellers from West Africa.Ìý |
Risk ratingÌý | Low – overall, Lassa fever is the most common imported viral haemorrhagic fever (VHF) but importations to the UK are still rare.Ìý |
Recent cases or outbreaksÌý | In Liberia, from 6 January 2022 to 30 October 2023, a total of 353 Lassa fever cases, including (CFR of 7.9%) were reported nationally. This is an increase of 6 confirmed cases since the last report. Between 1 January and 15 October 2023, Nigeria reported , with confirmed cases reported from 28 states. Among confirmed cases, 188 deaths have been reported (CFR of 17.2%). The number of reported cases and deaths is higher compared to the equivalent 2022 period (6,981 suspected and 941 confirmed cases, including 178 deaths among confirmed cases), while the CFR remains lower (18.9% in 2022). |
Marburg virus disease (MVD)
Geographical risk areasÌý | Sporadic outbreaks have previously been reported in Central and Eastern Africa. A human case of MVD was reported in ; this was the first case to be identified in West Africa. for the first time in July 2022. MVD outbreaks were reported for the first time in and in . |
---|---|
Sources and routes of infectionÌý | • exposure in mines or caves inhabited by Rousettus bat colonies • contact with infected human blood or body fluids |
UKÌýexperience to dateÌý | ÌýNo reported cases in the UK. |
Risk ratingÌý | Very low – globally, 5 travel-related exported MVD cases have previously been reported in the literature. |
Recent cases or outbreaksÌý | No confirmed or suspected human cases were reported in October 2023. |
´¡¾±°ù²ú´Ç°ù²Ô±ðÌýHCIDs
Avian influenza A(H7N9) virus
Geographical risk areasÌý | All reported human infections have been .Ìý | Ìý |
---|---|---|
Sources and routes of infectionÌý | • close contact with infected birds or their environmentsÌý • close contact with infected humans (no sustained human-to-human transmission)Ìý |
Ìý |
UKÌýexperience to date | No known cases in the UK.Ìý | Ìý |
Risk ratingÌý | ÌýVery low (UKHSAÌýrisk assessment).Ìý | Ìý |
Recent cases or outbreaksÌý | No confirmed or suspected human cases were reported in October 2023. | Ìý |
Avian influenza A(H5N1) virus
Geographical risk areasÌý | Human cases have been predominantly reported in South East Asia, but also in Egypt, Iraq, Pakistan, Turkey and Nigeria. Human cases (clade 2.3.4.4b) were and the , and and 2023. The first human cases of avian influenza A(H5N1) (clade 2.3.4.4b) were reported from South America in 2023, from and . |
---|---|
Sources and routes of infectionÌýÌý | • close contact with infected birds or their environments • close contact with infected humans (no sustained human-to-human transmission)Ìý |
UKÌýexperience to date | As of September 2023, 5 detections were reported in the UK, and 4 in 2023. |
Risk ratingÌý | ÌýVery low (UKHSAÌýrisk assessment).Ìý |
Recent cases or outbreaksÌý | On 8 October 2023, the Cambodian Ministry of Health in a 50-year-old male from Svay Rieng Province. On 9 October 2023 in a 2-year-old female from Prey Veng Province. Both cases had prior exposure to dead poultry in or around their homes. There is no evidence of human-to-human transmission in either instance. There have been 4 human cases (including 3 deaths) of avian influenza A(H5N1) reported in Cambodia in 2023, with the . These were the first human cases of avian influenza A(H5N1) reported in Cambodia since 2014. |
Middle East respiratory syndrome (MERS-CoV)
Geographical risk areasÌý | The Arabian Peninsula – Yemen, Qatar, Oman, Bahrain, Kuwait, Saudi Arabia and UnitedÌýArabÌýEmirates.Ìý |
---|---|
Sources and routes of infectionÌý | • airborne particles • direct contact with contaminated environmentÌý • direct contact with camels or consumption of raw camel milkÌý |
UKÌýexperience to dateÌý | – 3 imported cases (2012, 2013 and 2018), 2 secondary cases in close family members of the case in 2013, 3 deaths.Ìý |
Risk ratingÌý | ÌýVery low (UKHSAÌýrisk assessment).Ìý |
Recent cases or outbreaksÌý | No confirmed or suspected human cases were reported in October 2023. |
Mpox (Clade I only)
Geographical risk areasÌý | Central Africa including, .Ìý |
---|---|
Sources and routes of infectionÌýÌý | • close contact with an infected animal (in an endemic country) or an infected person • contact with clothing or linens (such as bedding or towels) used by an infected person • direct contact with mpox skin lesions or scabs • coughing or sneezing of an individual with an mpox rash • consumption of contaminated bushmeat |
UKÌýexperience to date | In June 2022, the Advisory Committee on Dangerous Pathogens (ACDP) recommended that the strain of monkeypox virus (MPXV) largely responsible for the global outbreak (Clade IIb, B.1 lineage) should no longer be classified as an HCID. In January 2023, the ACDP recommended that all Clade II MPXV should no longer be classified as an HCID. No cases of Clade I mpox have been reported in the UK. Between 2018 and 2021, 7 cases of mpox were identified in the UK which would no longer be classified as HCID mpox, but were treated as HCID cases at the time: 4 of the cases were imported from Nigeria, 2 cases were household contacts and one case was a healthcare worker involved in the care of an imported case. |
Risk ratingÌý | ÌýVery low – no known importations of Clade I mpox into the UK. |
Recent cases or outbreaksÌý | Sequencing data is rarely available for mpox cases reported from endemic African countries where clade I MPXV is known to circulate. During October 2023, , raising their 2023 total to 27 confirmed cases. The during October 2023, giving a cumulative total of 20 confirmed cases, including 2 deaths in 2023. |
Nipah virus
Geographical risk areasÌý | South East Asia, predominantly in . Cases have also been reported in Malaysia and Singapore. |
---|---|
Sources and routes of infectionÌý | • direct or indirect exposure to infected bats • consumption of contaminated raw date palm sap • close contact with infected pigs or humansÌý |
UKÌýexperience to dateÌýÌý | ÌýNo known cases in the UK.Ìý |
Risk ratingÌý | Exceptionally low/negligible – no travel-related infections in the literature.Ìý |
Recent cases or outbreaksÌý | No confirmed or suspected human cases were reported in October 2023. Between 12 and 15 September 2023, India’s Ministry of Health and Family Welfare reported , in Kozhikode District, Kerala. No further cases were reported in association with this outbreak. This was the sixth outbreak of Nipah virus in India since 2001. |
Pneumonic plague (Yersinia pestis)
Geographical risk areasÌý | Predominantly . Endemic in Madagascar, Peru, andÌýthe DRC. |
---|---|
Sources and routes of infectionÌý | • flea bitesÌý • close contact with infected animalsÌý • close contact with human cases of pneumonic plagueÌý |
UKÌýexperience to dateÌý | Last outbreak in the UK was in 1918.Ìý |
Risk rating | Exceptionally low/negligible |
Recent cases or outbreaksÌý | In Madagascar, on 3 October 2023, media reported , 4 of which were fatal, in Ankazobe District. A further 4 suspected fatal plague cases were reported by media; on 3 October 2023, and on 4 October 2023. It was not stated if these 4 cases were suspected to be pneumonic or bubonic plague. |
Severe acute respiratory syndrome (SARS)
Geographical risk areas | Currently none. Two historical outbreaks originating from China in 2002 and 2004. |
---|---|
Sources and routes of infection | • airborne particlesÌý • direct contact with contaminated environment |
UKÌýexperience to date | related to the 2002 outbreak.Ìý |
Risk rating | Exceptionally low/negligible |
Recent cases or outbreaks | No confirmed or suspected human cases reported globally since 2004.Ìý |
Incidents of significance of additionalÌýHCIDs
Argentine haemorrhagic fever (Junin virus)
Geographical risk areas | (central). Endemic to the provinces of Buenos Aires, Córdoba, Santa Fe and La Pampa. |
---|---|
Sources and routes of infection | • direct contact with infected rodentsÌý • inhalation of infectious rodent fluids and excretaÌý • person-to-person transmission has been documentedÌý |
UKÌýexperience to date | ÌýNo known cases in the UK.Ìý |
Risk rating | Exceptionally low/negligible – was identified in Belgium in 2020.Ìý |
Recent cases or outbreaks | No confirmed or suspected human cases were reported in October 2023. |
Bolivian haemorrhagic fever (Machupo virus)
Geographical risk areas | Bolivia – (Mamoré, Iténez and Yucuma provinces) and Cochabamba (Cercado province).Ìý |
---|---|
Sources and routes of infection | • direct contact with infected rodentsÌý • inhalation of infectious rodent fluids and excretaÌý • person-to-person transmission has been documentedÌý |
UKÌýexperience to date | ÌýNo known cases in the UK.Ìý |
Risk rating | Exceptionally low/negligible – travel-related cases have never been reported.Ìý |
Recent cases or outbreaks | No confirmed or suspected human cases were reported in October 2023. |
Lujo virus disease
Geographical risk areas | A single case acquired in Zambia led to a cluster in South Africa in 2008.Ìý |
---|---|
Sources and routes of infection | • presumed rodent contact (excreta, or materials contaminated with excreta of infected rodent)Ìý • person to person via body fluidsÌý |
UKÌýexperience to date | No known cases in the UK. |
Risk rating | Exceptionally low/negligible – a single travel-related case has been reported. No cases have been reported anywhere since 2008.Ìý |
Recent cases or outbreaks | No confirmed or suspected human cases reported since 2008.Ìý |
Severe fever with thrombocytopenia syndrome (SFTS)
Geographical risk areas | Mainly reported from China (south-eastern), Japan and Korea. Cases have also been reported in , , and . Serological evidence of SFTS in .Ìý |
---|---|
Sources and routes of infection | • presumed to be tick exposureÌý • person-to-person transmission described in household and hospital contacts, via contact with blood or bloodstained body fluidsÌý |
UKÌýexperience to date | No known cases in the UK.Ìý |
Risk rating | Exceptionally low/negligible – not known to have occurred in travellers.Ìý |
Recent cases or outbreaks | Between week 1 and 43 (up to 27 October) 2023, the Korean Disease Control and Prevention Agency reported in South Korea. Gyeonggi Region reported the most cases (31 cases), followed by Gangwon (26 cases). |
Andes virus (Hantavirus)
Geographical risk areas | ÌýChile and southern Argentina.Ìý |
---|---|
Sources and routes of infection | • rodent contact (excreta, or materials contaminated with excreta from an infected rodent)Ìý • person-to-person transmission described in household and hospital contactsÌý |
UKÌýexperience to date | ÌýNo known cases in the UK.Ìý |
Risk rating | ÌýVery low – rare cases in travellers have been reported.Ìý |
Recent cases or outbreaks | On 22 October 2023, , in which the species was not stated, was reported from Neuquén Province, Argentina, an Andes virus risk area. |
Avian influenza A(H5N6) virus
Geographical risk areas | Mostly China. New strain reported in , and subsequently found in Western Europe in birds.Ìý |
---|---|
Sources and routes of infection | Close contact with infected birds or their environments.Ìý |
UKÌýexperience to date | ÌýNo known cases in the UK.Ìý |
Risk rating | Very low – not known to have occurred in travellers (UKHSAÌýrisk assessment).Ìý |
Recent cases or outbreaks | No confirmed or suspected human cases were reported in October 2023. |
Avian influenza A(H7N7) virus
Geographical risk areas | Sporadic occurrence in birds across mainland Europe and the UK. in 1996, in 2003, and in 2013. |
---|---|
Sources and routes of infection | • close contact with infected birds or their environmentsÌý • close contact with infected humans (no sustained human-to-human transmission reported)Ìý |
UKÌýexperience to date | ÌýNo known cases in the UK.Ìý |
Risk rating | ÌýVery low – human cases are rare, and severe disease even rarer.Ìý |
Recent cases or outbreaks | No confirmed or suspected human cases were reported in October 2023. |
Authors of this report
Emerging Infections and Zoonoses Team, UKHSA